Product References — Animal Serum
Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium
Posted by Adam Awdish on
Innovative Grade US Origin Mouse Balb C Serum from Innovative Research was used in the following study: Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium Adam J. Replogle, Christopher Sexton, John Young, Luke C. Kingry, Martin E. Schriefer, Marc Dolan, Tammi L. Johnson, Neeta P. Connally, Kerry A. Padgett & Jeannine M. Petersen Scientific Reports January 21, 2021 When looking for proof of bacterial infection in a patient, primary culture recovery is the most common procedure to confirm an infection. Despite the rise in the number of infections over the last decade and the identification of...
In Vitro Validation Assessment of a Fecal Occult Blood Protein Test for Horses
Posted by Adam Awdish on
Horse Albumin Purified Lyophilized from Innovative Research was used in the following study: In Vitro Validation Assessment of a Fecal Occult Blood Protein Test for Horses Irena Rebalka, PhD; Michael I. Lindinger, PhD Journal of Equine Veterinary Science June 25, 2021 Unlike omnivorous or carnivorous animals, the presence of blood proteins in the feces of herbivores is not normal. Herbivores normally don’t consume animal proteins in their foods, and they typically have GI tracts with tight barriers, so the chance of blood proteins to be present in fecal matter resulting from the animal’s diet or from a leaky gut...
- Tags: Animal Blood Cells, Animal Serum, Animal Whole Blood, Innovative Grade US Origin Horse Whole Blood, Proteins
A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness
Posted by Adam Awdish on
Innovative Grade US Origin Rat Sprague Dawley Complement Serum from Innovative Research was used in the following study: A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness Adrianne I. Enos, Pamela S. Hair, Neel K. Krishna, Kenji M. Cunnion Molecular Immunology May 30, 2020 Platelet refractoriness, or the failure of transfused platelets to increase a patient’s platelet count that results in continued thrombocytopenia, is a concerning medical issue that has an urgent need for a solution. This continued state of thrombocytopenia can increase the risk of spontaneous bleeding in the patient and can result in increased medical expenses due to...
- Tags: Animal Serum, Innovative Grade US Origin Rat Sprague Dawley Serum, Innovative Grade US Origin Rat Wistar Complement Serum
Development of Rabbit Monoclonal Antibodies for Quantitation of Therapeutic Human Antibodies in Preclinical Non-Human Primate Studies
Posted by Adam Awdish on
Innovative Grade US Origin Monkey Cynomolgus Serum from Innovative Research was used in the following study: Development of Rabbit Monoclonal Antibodies for Quantitation of Therapeutic Human Antibodies in Preclinical Non-Human Primate Studies Ruiyin Chu, Jacob Gerstein, Hai Wu, Haibin Huang, Yang Lou, and Rachel Palmer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy October 21, 2020 In recent years, therapeutic monoclonal antibodies (mAbs) have become one of the fastest growing drug classes approved for the treatment of a wide range of indications. Preclinical characterization of these therapeutic mAbs often must be performed in non-human primates to prove their safety and efficacy...
Tranexamic Acid Analysis as Ethoxycarbonyl-tert-butyldimethylsilyl Derivatives by Gas Chromatography–Tandem Mass Spectrometry
Posted by Corey Marcath on
Innovative Grade US Origin Mouse Balb C Serum from Innovative Research was used in the following study: Tranexamic Acid Analysis as Ethoxycarbonyl-tert-butyldimethylsilyl Derivatives by Gas Chromatography–Tandem Mass Spectrometry Hyung-Jin Park, Hyeon-Seong Lee, Chan Seo, Jeuk Min, Moongi Ji, Youngbae Kim, Subin Choi, Doo-Young Kim, Jung Dong Kim, Do Hyeon Jeong, Wonjae Lee, and ManJeong Paik KOREAN CHEMICAL SOCIETY KOREAN CHEMICAL SOCIETY January 5, 2020 “…Tranexamic acid (TA, Figure 1) as a synthetic derivative of lysine is known as potent antifibrinolytic drug.1–4 TA interacts at the lysine-binding site of plasminogen molecules during fibrinolysis, which inhibit plasminogen activators from converting plasminogen...